MK-5172
MK-5172 is a novel P2-P4 quinoxaline macrocyclic HCV NS3/4a protease inhibitor currently in clinical development.
Product Specifications
CAS Number
1206524-85-7
Purity
>98%
Smiles
O1C (N ([H]) [C@] ([H]) (C (N2C ([H]) ([H]) C ([H]) (C ([H]) ([H]) C2 ([H]) C (=O) O[H]) OC2C (C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) C ([H]) ([H]) [C@]3 ([H]) C ([H]) ([H]) C13[H]) =NC1C ([H]) =C ([H]) C (=C ([H]) C=1N=2) OC ([H]) ([H]) [H]) =O) C (C ([H]) ([H]) [H]) (C ([H]) ([H]) [H]) C ([H]) ([H]) [H]) =O
Molecular Formula
C29H38N4O7
Molecular Weight
554.6346
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
